Related Experiment Video
Updated: May 8, 2026
07:35
Cognitive Function and Upper Limb Rehabilitation Training Post-Stroke Using a Digital Occupational Training System
Published on: December 29, 2023
Enhanced task-oriented training in a person with dementia with Lewy bodies
Carrie A Ciro1, Linda A Hershey, David Garrison
1Department of Rehabilitation Sciences, College of Allied Health, University of Oklahoma Health Sciences Center, 1200 Stonewall Avenue, Oklahoma City, OK 73117-1215, USA Carrie-ciro@ouhsc.edu
Summary
Skill-building through Task-Oriented Motor Practice (STOMP) shows promise for improving functional skills in individuals with dementia. This task-oriented training approach may help minimize functional loss and warrants further study in occupational therapy.
Area of Science:
- Neurology
- Occupational Therapy
- Neurorehabilitation
Background:
- Progressive dementias lead to inevitable functional loss, yet interventions remain understudied.
- Task-oriented training is supported by research, but clinical implementation faces practical evaluation and application gaps.
Observation:
- A case study explored the Skill-building through Task-Oriented Motor Practice (STOMP) intervention for a woman with moderate dementia with Lewy bodies.
- STOMP integrates task-oriented training with motor-learning principles to address functional deficits.
Findings:
- The STOMP intervention demonstrated potential in improving functional skills for the participant.
- The case study suggests STOMP can structure the evaluation and treatment of occupational performance deficits in dementia.
Implications:
- The STOMP model offers a structured approach for occupational therapy practice with individuals experiencing dementia.
- Further research is warranted to validate the efficacy and broader applicability of STOMP for managing functional decline in dementia.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...